Independently quantified peptide blend

Sulan Bio BPC-157 + TB-500 batch SUL0330-001 was independently analysed by Janoshik Laboratory under task #150942.

The analytical report recorded 11.98mg BPC-157 and 11.42mg TB-500 in the submitted sample, providing component-specific quantitative documentation for this marketplace listing.

Important: peptide purity was not included in this analysis. The report therefore documents the measured quantity of each component and should not be presented as a peptide-purity result.

What is the BPC-157 + TB-500 blend?

This research blend combines BPC-157 with TB-500 in a nominal 10mg + 10mg configuration. The two peptides are studied through different but potentially complementary areas of cellular and tissue biology.

BPC-157 is commonly investigated in experimental models involving cellular signalling, angiogenic pathways, fibroblast activity and tissue-remodelling processes.

TB-500 is associated with thymosin beta-4 (Tβ4) research and is commonly investigated in relation to actin regulation, cytoskeletal organisation, cell migration and tissue-remodelling pathways.

Common research areas

BPC-157 and TB-500-related pathways are commonly investigated in laboratory research examining:

• Cellular repair and regeneration signalling
• Cell migration and cellular motility
• Tissue-remodelling mechanisms
• Angiogenic and vascular signalling pathways
• Fibroblast and connective-tissue biology
• Actin regulation and cytoskeletal organisation
• Cell survival and stress-response pathways
• Inflammatory signalling in experimental models

Why study BPC-157 and TB-500 together?

The blend is of research interest because BPC-157 and TB-500 are associated with different areas of cellular signalling and tissue biology.

Experimental research may examine their respective effects on angiogenic signalling, fibroblast activity, actin dynamics, cell migration and tissue-remodelling pathways within the same laboratory model.

Available configuration

• BPC-157: nominal 10mg per vial
• TB-500: nominal 10mg per vial
• Total nominal peptide content: 20mg per vial
• Box configuration: 10 vials
• MOQ: 10 vials / 1 box
• Format: Lyophilized research peptide blend
• Supplier: Sulan Bio

Batch verification

• Supplier: Sulan Bio
• Batch: SUL0330-001
• Nominal blend: 10mg BPC-157 + 10mg TB-500
• Measured BPC-157: 11.98mg
• Measured TB-500: 11.42mg
• Measured combined content: 23.40mg
• Purity: Not included in this analysis
• Independent laboratory: Janoshik
• Task number: #150942
• Tested: 22 APR 2026
• COA status: Quantitative analysis available